Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
Canine osteosarcoma (OSA) is an aggressive malignancy that frequently metastasizes to the lung and bone. Not only has there been essentially no improvement in therapeutic outcome over the past 3 decades, but there is also a lack of reliable biomarkers in clinical practice. This makes it difficult to...
Main Authors: | Anita K. Luu, Geoffrey A. Wood, Alicia M. Viloria-Petit |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2021.734965/full |
Similar Items
-
MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma
by: Deanna D. Dailey, et al.
Published: (2021-04-01) -
MiRNAs from serum-derived extracellular vesicles as biomarkers for uveal melanoma progression
by: Joanna Patrycja Wróblewska, et al.
Published: (2022-12-01) -
MicroRNAs from Liquid Biopsy Derived Extracellular Vesicles: Recent Advances in Detection and Characterization Methods
by: Rares Drula, et al.
Published: (2020-07-01) -
Role of miRNA‐542‐5p in the tumorigenesis of osteosarcoma
by: Tengjiao Zhu, et al.
Published: (2020-04-01) -
Identification of key serum biomarkers for the diagnosis and metastatic prediction of osteosarcoma by analysis of immune cell infiltration
by: Zhihao Chen, et al.
Published: (2022-02-01)